Basic Information
Omixon is a global transplant diagnostics company with a mission to provide innovative technologies to histocompatibility laboratories to improve transplant outcomes. Headquartered in Budapest, Hungary, Omixon has branches in the United States, Brazil, and the Netherlands, serving more than 60 laboratories worldwide. In 2014, Omixon successfully launched the first NGS-based HLA typing kit and software, bringing the NGS-based HLA genotyping product Holotype HLA and HLA Twin software to market. Omixon Twin offers the most accurate high-resolution HLA genotyping and is used in more than 60 laboratories worldwide.
Omixon Biocomputing Ltd.
Budapest,Pest megye,Hungary
15~50 people
February 01, 2012
sales@omixon.com

